Alto Neuroscience, Inc. (ANRO) reports insider transaction.
- 10/02/2026 - 55,000 shares acquired
- Common stock price $2.32
- President and CFO Smith Nicholas Conrad
Nicholas Conrad Smith
ANRO
Alto Neuroscience, Inc. SEC filings
Every EDGAR filing for Alto Neuroscience, Inc. (ANRO), newest first, with AI summaries and stories.
- Ticker
- ANRO
- CIK
- 1999480
- Latest filing
- Oct 5
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
4Alto Neuroscience, Inc.ANROLIVE 4Alto Neuroscience, Inc.ANROLIVE Nicholas Conrad Smith, insider filing for ANRO
Nicholas Conrad Smith
144Alto Neuroscience, Inc.ANROLIVE Nicholas Conrad Smith, planned sale of ANRO shares
Nicholas Conrad Smith, reporting
8-KAlto Neuroscience, Inc.ANROLIVE SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
PERCEPTIVE ADVISORS LLC, filed by
SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by Vestal Point Capital, LP (amended)
Vestal Point Capital, LP, filed by
SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by Sirenia Capital Management LP (amended)
Sirenia Capital Management LP, filed by
10-QAlto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE SCHEDULE 13GAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
SCHEDULE 13GAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by EcoR1 Capital, LLC
EcoR1 Capital, LLC, filed by
424B5Alto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE 4Alto Neuroscience, Inc.ANROLIVE 2 insider filings
Andrew Craig Miller, insider filing for ANRO
Show all 2
- 4Insider filing for ANRO
- 3New insider at ANRO
Andrew Craig Miller, reporting
8-KAlto Neuroscience, Inc.ANROLIVE SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE 3 13G filings
Ownership stake disclosure by Vestal Point Capital, LP (amended)
Show all 3
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Vestal Point Capital, LP, filed by
4Alto Neuroscience, Inc.ANROLIVE Amit Etkin, insider filing for ANRO
Amit Etkin, reporting
SCHEDULE 13GAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
4Alto Neuroscience, Inc.ANROLIVE 5 insider filings
Ramiro Sanchez, insider filing for ANRO
Show all 5
- 4Insider filing for ANRO
- 4Insider filing for ANRO
- 4Insider filing for ANRO
- 4Insider filing for ANRO
- 4Insider filing for ANRO
Ramiro Sanchez, reporting
8-KAlto Neuroscience, Inc.ANROLIVE 10-QAlto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE EFFECTAlto Neuroscience, Inc.ANROLIVE S-3Alto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE ARSAlto Neuroscience, Inc.ANROLIVE DEFA14AAlto Neuroscience, Inc.ANROLIVE DEF 14AAlto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE S-8Alto Neuroscience, Inc.ANROLIVE 10-KAlto Neuroscience, Inc.ANROLIVE 8-KAlto Neuroscience, Inc.ANROLIVE 4Alto Neuroscience, Inc.ANROLIVE 2 insider filings
Amit Etkin, insider filing for ANRO
Show all 2
- 4Insider filing for ANRO
- 4Insider filing for ANRO
Amit Etkin, reporting
SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
SCHEDULE 13G/AAlto Neuroscience, Inc.ANROLIVE 5 13G filings
Ownership stake disclosure by K2 HealthVentures Equity Trust LLC (amended)
Show all 5
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13G/AOwnership stake disclosure (amended)
K2 HealthVentures Equity Trust LLC, filed by
4Alto Neuroscience, Inc.ANROLIVE Amit Etkin, insider filing for ANRO
Amit Etkin, reporting